Conceptus to Hold Conference Call On March 22, 2000.

Health/Medical Writers

SAN CARLOS, Calif.--(BW HealthWire)--March 20, 2000

Conceptus, Inc. (NASDAQ NM: CPTS) today announced that the Company will hold a conference call on Wednesday, March 22, 2000 beginning at 4:30 p.m. Eastern Time to discuss fourth quarter and year-end results, as well as year 2000 milestones. To access the call, please dial [phone]. A telephone replay will be available until 6:30 p.m. Eastern Time March 24, by dialing [phone], reservation number 14579447.

In addition, investors can listen to the conference call via the Internet through Vcall at www.vcall.com. To listen to the live call, please visit the Web site a few minutes prior to the start of the call to register, download and install the necessary audio software. A replay will be available on the site for 90 days.

Conceptus, Inc. is developing STOP(TM), an innovative medical device designed to provide a non-surgical alternative to the leading form of contraception worldwide, surgical tubal sterilization. Data from the United Nations show that worldwide, 30% of reproductive couples using contraception rely on surgical tubal sterilization. A survey performed by the Centers for Disease Control indicates that surgical tubal sterilization is the No. 1 form of contraception in the U.S., and that 35% of women age 35-44 have had a surgical tubal sterilization. An estimated 800,000 tubal ligations are performed each year in the U.S., of which 90% are performed in a hospital or surgi-center and require general anesthesia.

STOP is a proprietary micro-coil that is designed to be deployed permanently into each fallopian tube using the Company's minimally invasive tubal access and delivery system and a unique delivery wire. Once in place, STOP is designed to induce a benign tissue response that occludes the lumen of the fallopian tubes.